Skip to content
★ Sign in to follow
HI

HealthyWay Inc. Stock: price and insider trades · Hong Kong

HK·Mcap HK$524.6MHealth Care

No insider purchase over the last 90 days. The latest, by Zhang Wanneng, was filed 28 Apr 2026.

HealthyWay Inc.: what insiders have been doing

HealthyWay Inc., classified in the Health Care sector, is a listed company. Its insiders report their share dealings to HKEX. Over the twelve months to 22 October 2026, 22 filings were filed, from 2 insiders.

The record shows 19 purchases on the open market worth €1.8M, made by 1 insider, against 3 sales worth €613k by 1 insider. The net balance comes to €1.2M on the buying side. Open-market purchases are the filings investors watch most closely, because the insider pays for the shares out of pocket. At €412k, the purchase published on 30 January 2026 by Zhang Wanneng is the largest of the period. Among those who bought: 1 senior executive.

The last purchase on record was published on 28 April 2026, which is 194 days ago. Typically, a trade is published a median of 2 days after it takes place. That lag is the time during which only the insider knows about the trade.

Across the 1,314 companies tracked on its exchange, the median is 4 filings; at 22 filings, this issuer sits above that mark. Our records for HealthyWay Inc. go back to 2025, with 19 purchases and 3 sales on the open market in total.

In the same sector, recent insider purchases at UCB also feature in our signals. Source: insider filings from HKEX. Past trades are no guide to future returns.

Insider Decl.
22
Thresholds
n/a
Buy Volume
€2M
19 ops. · all time
Sell Volume
€612,752
3 ops. · all time

Who traded when

BuySale
Zhang Wanneng19 buys
Chen Yong3 sales

Since the insiders bought

  • Filed 28 Apr 2026 · 194 days ago · €43k
    -85.4%
    Entry HK$4.21 · Close 21 Oct 2026 HK$0.62

Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.

This score ranks the purchase within its own market. A position size is suggested only on the venues of the backtested strategy universe; elsewhere, signals stay on watch. Not investment advice.

Fundamental score
Ranked 2,449 of 26,897 companies
74.9
score / 100
Value
84
Quality
66
FCF yld7.7%
Earn yld11%
EV/EBITDA4.6x
ROE22%
Gross mgn30%
Net mgn3.6%
Debt/EBITDA0.3x
Pillars2/3

Transparent value + quality ranking, distinct from the insider signal.

Financial data

as of FY 2025

FY ended December 2025 · cache

HK$0.60
Analyst consensus
·
Income statement
RevenueHK$1.6B
Gross profitHK$476.3M30% margin
EBITDAHK$123.5M8% margin
Net incomeHK$55.7M3.2% margin
Valuation
PER (trailing)8.6x
P/Book1.7x
Balance sheet & cash
Market capHK$524.6M
Total debtHK$41.2M
Free Cash FlowHK$40.2M
Debt / Equity8%
Profitability & ownership
ROE22.1%
ROA5.6%
% insiders59.8%
% institutions0.9%
Last declaration on 28 April 2026
Declarations22 total
  • ▲
    DirectorExecutives
    396,471 HKD12HKEX
    90,500 shares@ HK$4.38090.025% mcap12.1% of flowShareXHKGHKEX:DA20260427E00465
    Canonical exit: 23 Jul 2026 (T+90)
  • ▲
    DirectorExecutives
    1M HKD5HKEX
    233,000 shares@ HK$4.50180.065% mcap32.0% of flowShareXHKGHKEX:DA20260423E00496
    Canonical exit: 22 Jul 2026 (T+90)
  • ▲
    DirectorExecutives
    236,808 HKD3HKEX
    51,000 shares@ HK$4.64330.015% mcap7.2% of flowShareXHKGHKEX:DA20260417E00546
    Canonical exit: 16 Jul 2026 (T+90)
  • ▼
    DirectorExecutives
    2M HKD6HKEX
    350,000 shares@ HK$4.78590.10% mcap42.8% of flowShareXHKGHKEX:DA20260417E00338
  • ▲
    DirectorExecutives
    973,751 HKD5HKEX
    206,500 shares@ HK$4.71550.060% mcap29.4% of flowShareXHKGHKEX:DA20260417E00363
    Canonical exit: 15 Jul 2026 (T+90)
  • ▲
    DirectorExecutives
    642,229 HKD4HKEX
    137,000 shares@ HK$4.68780.039% mcap19.4% of flowShareXHKGHKEX:DA20260416E00389
    Canonical exit: 14 Jul 2026 (T+90)
  • ▼
    DirectorExecutives
    2M HKD8HKEX
    470,000 shares@ HK$4.69440.14% mcap57.2% of flowShareXHKGHKEX:DA20260327E00229
  • ▼
    DirectorExecutives
    2M HKD14HKEX
    300,000 shares@ HK$5.808530.8% of flowShareXHKGHKEX:DA20260227E00158
  • ▲
    DirectorExecutives
    4M HKD13HKEX
    780,000 shares@ HK$4.954923.1% of flowShareXHKGHKEX:DA20260130E00408
    Canonical exit: 28 Apr 2026 (T+90)
  • ▲
    DirectorExecutives
    645,164 HKD11HKEX
    130,000 shares@ HK$4.96283.9% of flowShareXHKGHKEX:DA20260127E00511
    Canonical exit: 27 Apr 2026 (T+90)
  • ▲
    DirectorExecutives
    656,821 HKD11HKEX
    133,000 shares@ HK$4.93854.0% of flowShareXHKGHKEX:DA20260126E00556
    Canonical exit: 26 Apr 2026 (T+90)
  • ▲
    DirectorExecutives
    508,878 HKD11HKEX
    102,000 shares@ HK$4.9893.1% of flowShareXHKGHKEX:DA20260122E00650
    Canonical exit: 22 Apr 2026 (T+90)
  • ▲
    DirectorExecutives
    554,345 HKD11HKEX
    110,000 shares@ HK$5.03953.4% of flowShareXHKGHKEX:DA20260121E00578
    Canonical exit: 21 Apr 2026 (T+90)
  • ▲
    DirectorExecutives
    2M HKD12HKEX
    327,000 shares@ HK$4.95710.0% of flowShareXHKGHKEX:DA20260119E00704
    Canonical exit: 19 Apr 2026 (T+90)
  • ▲
    DirectorExecutives
    561,344 HKD11HKEX
    112,000 shares@ HK$5.0123.5% of flowShareXHKGHKEX:DA20260116E00629
    Canonical exit: 16 Apr 2026 (T+90)
  • ▲
    DirectorExecutives
    429,436 HKD11HKEX
    98,000 shares@ HK$4.3822.6% of flowShareXHKGHKEX:DA20251230E00362
    Canonical exit: 30 Mar 2026 (T+90)
  • ▲
    DirectorExecutives
    410,404 HKD11HKEX
    94,000 shares@ HK$4.3662.5% of flowShareXHKGHKEX:DA20251219E00244
    Canonical exit: 17 Mar 2026 (T+90)
  • ▲
    DirectorExecutives
    429,128 HKD11HKEX
    97,000 shares@ HK$4.4242.6% of flowShareXHKGHKEX:DA20251218E00359
    Canonical exit: 16 Mar 2026 (T+90)
  • ▲
    DirectorExecutives
    609,830 HKD11HKEX
    130,000 shares@ HK$4.6913.7% of flowShareXHKGHKEX:DA20251217E00632
    Canonical exit: 12 Mar 2026 (T+90)
  • ▲
    DirectorExecutives
    658,631 HKD11HKEX
    144,500 shares@ HK$4.5584.1% of flowShareXHKGHKEX:DA20251216E00027
    Canonical exit: 11 Mar 2026 (T+90)
  • ▲
    DirectorExecutives
    1M HKD12HKEX
    258,000 shares@ HK$4.7117.5% of flowShareXHKGHKEX:DA20251215E00314
    Canonical exit: 10 Mar 2026 (T+90)
  • ▲
    DirectorExecutives
    948,000 HKD12HKEX
    200,000 shares@ HK$4.745.9% of flowShareXHKGHKEX:DA20251212E00330
    Canonical exit: 9 Mar 2026 (T+90)

22 of 22 declarations

About HealthyWay Inc.

HealthyWay Inc. is a company focused on the health and pharmaceutical sector. It is listed on the Hong Kong Stock Exchange.